Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05403385
Title	Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	iTeos Belgium SA
Indications	lung non-squamous non-small cell carcinoma
Therapies	Carboplatin + EOS100850 + Pemetrexed Disodium Carboplatin + Pemetrexed Disodium
Age Groups:	senior \| adult
Covered Countries	USA \| POL \| ITA \| GBR \| FRA \| ESP \| DEU \| CZE \| CHE \| CAN \| BEL